Clinical Trial

Stellate Ganglion Block in Complex Regional Pain Syndrome

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 5, 2025 (before its estimated October 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim was to investigate the effect of Stellate Ganglion Blockade, which will be applied in addition to conventional physical therapy, on pain and functionality in patients with poststroke complex regional pain syndrome.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-12.
Trial Details
NCT Number NCT07129811
Lead Sponsor Ankara City Hospital Bilkent
Conditions Stellate Ganglion Block
Enrollment 32 participants
Start Date 2025-01-15
Primary Completion 2025-10-31 (estimated)
Study Completion 2025-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-05